-
公开(公告)号:ZA8108968B
公开(公告)日:1982-11-24
申请号:ZA8108968
申请日:1981-12-29
Applicant: HOECHST AG
IPC: A61K31/425 , A61K31/426 , A61P3/06 , A61P9/10 , C07D277/18 , C07D277/20 , C07D277/42 , C07D
CPC classification number: C07D277/18 , C07D277/42
-
公开(公告)号:ZA8003979B
公开(公告)日:1981-06-24
申请号:ZA8003979
申请日:1980-07-02
Applicant: HOECHST AG
IPC: A61K31/425 , A61K31/426 , A61P3/06 , A61P9/10 , C07C275/66 , C07C335/36 , C07D277/18 , C07D277/20 , C07D277/42 , C07D317/66 , C07D319/18 , C07D417/12 , C07D
CPC classification number: C07D319/18 , C07C275/66 , C07C309/00 , C07C335/36 , C07D277/18 , C07D277/42 , C07D317/66
-
公开(公告)号:ZA796651B
公开(公告)日:1981-05-27
申请号:ZA796651
申请日:1979-12-07
Applicant: HOECHST AG
IPC: A61K31/415 , A61K31/505 , A61P3/04 , A61P3/06 , C07D239/48 , C07D403/04 , C07D403/12 , C07D405/12 , C07D405/14 , C07D
Abstract: What is disclosed are 4-amino-2-ureido (or -thioureido)-pyrimidine-5-carboxylic acid anilides of the formula further defined in the specification, and physiologically acceptable acid addition salts thereof, methods for treating adiposity and disturbances of the lipometabolism with these compounds or salts, and pharmaceutical compositions containing these compounds or salts and useful for inducing anorexia or affecting the lipometabolism.
-
公开(公告)号:SE407938B
公开(公告)日:1979-04-30
申请号:SE7406595
申请日:1974-05-17
Applicant: HOECHST AG
Inventor: KUNSTMANN R , GRANZER E
IPC: C07D221/16
Abstract: Partially hydrogenated 1H-indeno[1,2-b]-pyridine derivatives of the general formula I in which R1 and R2, which may be identical or different, represent hydrogen, halogen or alkoxy of 1 to 4 carbon atoms, R3 represents pyridyl, phenyl, or phenyl mono- or di-substituted by halogen, nitro, amino, acylamino, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, or amino substituted by 1 or 2 aliphatic or aromatic hydrocarbon groups having 2 to 18 carbon atoms or substituted amino wherein the amino-nitrogen is included in a heterocycle, A represents a single or double bond, and X represents oxygen or sulfur, AND THEIR PHYSIOLOGICALLY TOLERATED SALTS, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
-
公开(公告)号:ZA777584B
公开(公告)日:1978-11-29
申请号:ZA777584
申请日:1977-12-21
Applicant: HOECHST AG
Inventor: GEBERT U , GREVE H , GRANZER E , THORWART W
IPC: C07D295/08 , A61K31/445 , A61K31/451 , A61K31/495 , A61P3/06 , A61P9/00 , A61P9/10 , A61P9/12 , A61P19/06 , C07D209/14 , C07D211/14 , C07D213/53 , C07D213/80 , C07D295/088 , C07D303/12 , C07D303/36 , C07D333/22 , C07D409/12 , A61K31/15 , A61K31/50 , C07C131/00
Abstract: Compounds of general formula (I) wherein R1 represents a member selected from the group consisting of (a) an unsubstituted at most binuclear aryl group having from 6 to 10 carbon atoms, such groups substituted by from 1 to 3 equal or different radicals selected from the group consisting of alkyl, halogenoalkyl, alkoxy, dialkylamino each having up to 4 carbon atoms in the alkyl moiety, halogen phenyl, carboxyl, cyano, nitro and hydroxy groups, (b) a 5- to 6-membered heteroaromatic ring wherein the heteroatom is selected from nitrogen, oxygen and sulfur atoms and such rings anellated to a benzene nucleus; R2 represents a member selected from the group consisting of hydrogen, alkyl having up to 3 carbon atoms, phenyl, cycloalkyl having up to 6 carbon atoms in the ring and cycloalkyl bearing a hydrocarbon bridging radical having up to 2 carbon atoms; R3 represents hydrogen, hydroxy or acyloxy; R4 and R5 are the same or different and each represents a member selected from the group consisting of halogen, alkyl, and halogenoalkyl each having up to 3 carbon atoms, and nitro; and X represents nitrogen or methine and physiologically acceptable acid addition salts thereof and a pharmaceutical composition containing said compounds.
-
公开(公告)号:DK391677A
公开(公告)日:1978-03-05
申请号:DK391677
申请日:1977-09-02
Applicant: HOECHST AG
IPC: A61K31/195 , A61K31/38 , A61K31/381 , A61P3/06 , C07C229/38 , C07C233/81 , C07C235/52 , C07D333/38 , C07C
Abstract: Benzoic acids of the general formula I I in which R, R1, R2 and Y have the meanings as mentioned in the following, and which in the form of the free compounds or in the form of the physiologically tolerated salts and esters possess valuable pharmacological properties, processes for preparing them, pharmaceutical preparations containing them, and their use as or in medicaments.
-
公开(公告)号:SE7709333A
公开(公告)日:1978-02-21
申请号:SE7709333
申请日:1977-08-18
Applicant: HOECHST AG
IPC: C07D213/80 , C07D213/85
CPC classification number: C07D213/80 , C07C255/00 , C07D213/85
-
公开(公告)号:DK370277A
公开(公告)日:1978-02-21
申请号:DK370277
申请日:1977-08-19
Applicant: HOECHST AG
IPC: C07D213/80 , C07D213/85 , C07D
-
公开(公告)号:ZA751397B
公开(公告)日:1976-02-25
申请号:ZA751397
申请日:1975-03-07
Applicant: HOECHST AG
Inventor: MUSIL J , BARTMANN W , GRANZER E , TEUFEL H
IPC: C07C20060101 , C07C255/34
-
公开(公告)号:SE7502557A
公开(公告)日:1975-09-10
申请号:SE7502557
申请日:1975-03-07
Applicant: HOECHST AG
Inventor: TEUFEL H , BARTMANN W , GRANZER E , MUSIL J
IPC: C07C251/32 , A61K20060101 , A61K31/00 , A61K31/11 , A61K31/15 , A61K31/275 , C07C20060101 , C07C47/38 , C07C67/00 , C07C253/00 , C07C255/34 , C07C255/35 , C07C255/53 , C07C121/00
CPC classification number: C07C255/00
-
-
-
-
-
-
-
-
-